Ingredient

Roflumilast Micronized

Roflumilast is a medication for relieving symptoms of chronic obstructive pulmonary disease.

See medicines used for Respiratory & Infection
All medicines
2
Single ingredient
2
Prescription medication
2

MFDS ingredient code M252180

What does it do?

Roflumilast is a selective phosphodiesterase-4 (PDE4) inhibitor used in the treatment of chronic obstructive pulmonary disease. It reduces inflammation to alleviate respiratory symptoms. It is formulated in a micronized form to enhance its absorption in the body.

Roflumilast inhibits the enzyme PDE4, which causes inflammation in lung tissue, thereby decreasing the activation and secretion of inflammatory cells. As a result, inflammation in the airways is reduced, making breathing easier and alleviating symptoms.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Roflumilast, unlike other respiratory medications, is a PDE4 inhibitor focused on inflammation control, differing in its mechanism of action from bronchodilators. The micronized form improves the bioavailability of the drug, enhancing its effectiveness.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

2 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.